Physician profile
Vivek Thappa
NPI 1295743383
$6,778.25
in general payments reported to CMS, 2019-2025
30 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 76% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,813 · 2020: $499 · 2021: $555 · 2022: $216 · 2023: $1,470 · 2024: $941 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,647 · Travel and Lodging: $835 · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.48 |
| Travel and Lodging | $834.96 |
| Education | $212.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,504.16 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,126.10 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Intuitive Surgical, INC. | $988.79 | 2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $689.99 | 2019-2025 | Nucala, Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $652.07 | 2019-2025 | |
| Genzyme Corporation | $294.56 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $168.83 | 2020-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $162.03 | 2019-2020 | |
| Genentech USA, INC. | $157.89 | 2019-2020 | |
| Philips North America LLC | $119.97 | 2019-2025 | Vest Therapy Und, Disposable Vest, (Ak6) Vest Therapy |
| Inspire Medical Systems, INC. | $115.37 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $100.69 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $85.43 | 2019 | |
| Amgen INC. | $85.03 | 2024-2025 | Tezspire |
| Mylan Specialty L.P. | $81.60 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $62.32 | 2024-2025 | Sunosi |
| Abbvie INC. | $52.74 | 2023 | Avycaz |
| Verona Pharma, INC. | $49.78 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $46.65 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.78 | 2021-2022 | |
| United Therapeutics Corporation | $30.80 | 2019-2021 | |
| Grifols USA, LLC | $24.35 | 2024 | Prolastin-C Liquid |
| Vapotherm INC | $24.29 | 2019 | |
| Lilly USA, LLC | $18.46 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $18.29 | 2020 | |
| Ambu INC. | $17.65 | 2023 | |
| Mallinckrodt Hospital Products INC. | $16.28 | 2021 | |
| Shire North American Group INC | $14.23 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.12 | 2020 | |
| Veran Medical Technologies, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Thappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.